amrinone also known inamrinone sold inocor pyridine phosphodiesterase drug may improve prognosis patients congestive heart amrinone shown increase contractions initiated heart highgain calcium induced calcium release positive inotropic effect amrinone mediated selective enhancement highgain cicr contributes contraction myocytes phosphorylation camp dependent protein kinase pka calmodulin kinase increases cardiac contractility vasodilator acts inhibiting breakdown camp cgmp phosphodiesterase enzyme longstanding controversy regarding whether drug actually increases cardiac contractility diseased myocardium therefore whether clinical use issue reviewed extensively dr peter wilmshurst one first cardiologists researchers question drugs pde iii present cardiac muscle vascular smooth muscle platelets pde iii degrades phosphodiester bond camp break pde iii inhibited camp inactivated increase camp administration amrinone vascular smooth muscle produces vasodilation facilitating calcium uptake sarcoplasmic reticulum special type smooth er decreasing calcium available myocytes increase camp concentration increases turn activity pka kinase improves inward current ltype channels leads calciuminduced calcium release sarcoplasmic reticulum giving rise calcium spark triggers contraction results inotropic effect furthermore pka phosphorylates deactivates phospholambans inhibit serca enzymatic pump terminate contraction removes cytoplasm stores back sarcoplasmic reticulum promotes subsequent arterial relaxation well producing lusitropic effect inotropic lusitropic effects justify use amrinone treat heart failure amrinone decreases pulmonary capillary wedge pressure increasing cardiac output functions arterial vasodilator increases venous capacitance decreasing venous net decrease myocardial wall tension consumption using amrinone amrinone also beneficial effects diastole left ventricle including relaxation compliance filling patients congestive heart shortterm management severe chf used long term increased mortality probably due heart failure congestive heart failure chf characterized reduction ventricular performance abnormalities peripheral circulation reduced release endothelium derived relaxing factor edrf causes decrease stimulation guanylate cyclase cyclic gmp cgmp levels fall vascular smooth muscle impairs relaxation vasculature part vicious cycle patients chf downregulation adrenergic receptors alters ability activate intracellular adenylate cyclase catalyzes camp camp second messenger controls level calcium available allow heart contract iv administration amrinone shown increase cardiac output co stroke volume sv concurrently reducing filling pressure left ventricle decreasing resistance peripheral lead increase heart rate blood improvement performance ventricles likely result direct stimulation depressed myocardium well decrease peripheral vascular patients aortic stenosis hypertrophic cardiomyopathy history hypersensitivity drug may increase myocardial ischemia blood pressure pulse ecg constantly monitored amrinone diluted normal saline normal saline dextrose solutions used furosemide loop diuretic administered iv line delivering amrinone thrombocytopenia prominent doserelated side effect transient asymptomatic nausea diarrhea hepatotoxicity arrhythmias fever adverse effects early studies patients heart failure showed amrinone produced shortterm hemodynamic improvement limited longterm clinical serious side effects long term administration included sustained ventricular tachycardia resulting circulatory collapse worsening myocardial ischemia acute myocardial infarction worsening congestive heart amrinone good absorption gastrointestinal tract led gastrointestinal upset taken orally oral form drug longer currently acute intravenous administration takes effects amrinone vary widely species experimental condition therefore inotropic effects loss sensitivity phosphodiesterase inhibitors including amrinone observed end stage heart failure humans treatment options may useful improvement amrinone inn inamrinone united states adopted name adopted attempt avoid confusion see also milrinone pelrinone httpsenwikipediaorgwikiamrinone